(R)-3-(Hexanoyloxy)-2-((12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecanoyl)oxy)propyl (2-(trimethylammonio)ethyl) phosphate

Catalog No. :
ACQTVL068
CAS No. :
328946-23-2
Molecular Formula :
C32H54N5O11P
Molecular Weight :
715.78

IUPAC Name:(R)-3-(hexanoyloxy)-2-((12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecanoyl)oxy)propyl (2-(trimethylammonio)ethyl) phosphate

(R)-3-(Hexanoyloxy)-2-((12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecanoyl)oxy)propyl (2-(trimethylammonio)ethyl) phosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-3-(Hexanoyloxy)-2-((12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecanoyl)oxy)propyl (2-(trimethylammonio)ethyl) phosphate
IUPAC Name(R)-3-(hexanoyloxy)-2-((12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecanoyl)oxy)propyl (2-(trimethylammonio)ethyl) phosphate
Molecular FormulaC32H54N5O11P
Molecular Weight715.78
SMILESCCCCCC(OC[C@@H](OC(CCCCCCCCCCCNC1=CC=C([N+]([O-])=O)C2=NON=C21)=O)COP(OCC[N+](C)(C)C)([O-])=O)=O
InChI KeyRNJMBWCNJCHTOS-AREMUKBSSA-N
Synonym06:0-12:0 NBD PC;1-CAPROYL-2-[12-[(7-NITRO-2-1,3-BENZOXADIAZOL-4-YL) AMINO]DODECANOYL]-SN-GLYCERO-3-PHOSPHOCHOLINE
CAS No.328946-23-2

Synthetic Route by SureRoute

1. ACQTVL068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQTVL068 route product structure diagram
    ACQTVL068328946-23-2
Inquiry

2. ACQTVL068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQTVL068 route product structure diagram
    ACQTVL068328946-23-2
Inquiry

Comments (0)